Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Januvia (sitagliptin) and Tradjenta (linagliptin) are both prescription medications used to treat Type 2 diabetes and belong to the same drug class, dipeptidyl peptidase 4 (DPP-4) inhibitors. Januvia is typically taken at 100 mg once daily, while Tradjenta is taken at 5 mg once daily. One key difference is that Januvia may require dose adjustments for people with kidney problems, whereas those can take Tradjenta for people with kidney or liver issues without dose changes. Common side effects for Januvia include a runny nose, sore throat, and headache, while Tradjenta may cause runny nose, sneezing, and diarrhea. Both medications can cause severe joint pain and have rare risks of pancreatitis and heart failure. However, Tradjenta has a higher reported rate of common cold symptoms compared to Januvia. Neither medication is known to affect body weight significantly on its own, but weight changes can occur when taken with other diabetes medications.
Januvia (sitagliptin)
Tradjenta (linagliptin)
Januvia (sitagliptin)
Tradjenta (linagliptin)
Summary of Januvia vs. Tradjenta
Summary for DDP-4 inhibitor
Prescription only
Januvia (sitagliptin) is a prescription medication used along with a healthy diet and exercise to treat Type 2 diabetes. It belongs to the drug class dipeptidyl peptidase-4 (DPP-4) inhibitor, also known as gliptins. Januvia (sitagliptin) is taken by mouth, typically once daily. Most people don't experience many side effects from this medication, but possible ones include stuffy or runny nose, sore throat, and headache.
Summary for DDP-4 inhibitor
Prescription only
Tradjenta (linagliptin) is a prescription medication that's used along with a balanced diet and exercise to manage blood sugar levels in adults with Type 2 diabetes. It's a type of diabetes medication called a dipeptidyl peptidase-4 (DPP-4) inhibitor. The dose is 5 mg (1 tablet) that's taken by mouth once per day. Tradjenta (linagliptin) doesn't cause many side effects but can sometimes include runny nose, sneezing, and diarrhea. As of 2024, Tradjenta (linagliptin) is available as a brand-name medication only; there's no generic version yet.